Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

60 Degrees Pharmaceuticals Inc. (SXTP) vs VivoSim Labs, Inc. (VIVS)

60 Degrees Pharmaceuticals Inc. and VivoSim Labs, Inc. are both Biotechnology companies. 60 Degrees Pharmaceuticals Inc. and VivoSim Labs, Inc. are of similar size ($4.1M and $3.9M). 60 Degrees Pharmaceuticals Inc. grew revenue faster over the last twelve months: 23.4% against −21.1%. 60 Degrees Pharmaceuticals Inc. has the higher net margin (−650.3% vs −11,016.1%) and the lower return on invested capital (−348.6% vs 0.00%). Across the 16 metrics below, 60 Degrees Pharmaceuticals Inc. leads on 11 and VivoSim Labs, Inc. on 5.

Valuation

Metric SXTP VIVS Biotechnology median
P/E n/m n/m 7.88
P/S 2.56 10.29 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.05 0.74
EV/Sales 1.84 (4.61) 10.73
Earnings yield (185.50%) (2,031.82%) (28.84%)
Free cash flow yield (291.87%) (104.63%) (23.03%)

Profitability

Metric SXTP VIVS Biotechnology median
Gross margin 43.42% 100.00% 65.16%
Operating margin (691.33%) (10,116.96%) 0.00%
Net margin (650.34%) (11,016.07%) 0.00%
Free cash flow margin (745.93%) (1,014.29%) 0.00%
Return on equity 110.82% (343.10%) (57.72%)
Return on assets (186.70%) (155.93%) (49.22%)
Return on invested capital (348.64%) 0.00% 0.00%

Growth

Metric SXTP VIVS Biotechnology median
Revenue growth (TTM) 23.41% (21.13%) 5.64%
EPS growth (last fiscal year) 84.19% (214.71%) —
Revenue growth, 5-year CAGR (11.18%) (43.10%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SXTP VIVS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 1.70 4.73
Net debt to EBITDA 0.37 0.45 0.96

Dividend

Metric SXTP VIVS Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric SXTP VIVS Biotechnology median
Market cap 4.08m 3.92m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack